Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Marsden

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|September 1, 1987
Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomasP Dias, P Kumar, H B Marsden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor StudyJ Pritchard, J Imeson, J Barnes, et al.
British Journal of Cancer|November 10, 2004
Long-term population-based risks of second malignant neoplasms after childhood cancer in BritainH C Jenkinson, M M Hawkins, C A Stiller, et al.
Journal of the National Cancer Institute|August 1, 1984
Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomasH Shimada, J Chatten, W A Newton, et al.
Medical and Pediatric Oncology|January 1, 1989
Histopathological classification of childhood rhabdomyosarcoma: a report from the International Society of Pediatric Oncology pathology panelJ M Caillaud, R Gérard-Marchant, H B Marsden, et al.
Journal of the National Cancer Institute|March 6, 1996
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancerM M Hawkins, L M Wilson, H S Burton, et al.
BMJ (Clinical Research Ed.)|April 11, 1992
Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancerM M Hawkins, L M Wilson, M A Stovall, et al.
Journal of Clinical Pathology|April 1, 1991
Congenital mesoblastic nephroma: possible prognostic and management value of assessing DNA contentJ C Barrantes, C Toyn, K R Muir, et al.
British Journal of Cancer|July 27, 2007
A study of soft tissue sarcomas after childhood cancer in BritainH C Jenkinson, D L Winter, H B Marsden, et al.
Pediatric Blood & Cancer|February 18, 2004
Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) studyR G Grundy, C Hutton, H Middleton, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|September 1, 1987
Evaluation of desmin as a diagnostic and prognostic marker of childhood rhabdomyosarcomas and embryonal sarcomasP Dias, P Kumar, H B Marsden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor StudyJ Pritchard, J Imeson, J Barnes, et al.
British Journal of Cancer|November 10, 2004
Long-term population-based risks of second malignant neoplasms after childhood cancer in BritainH C Jenkinson, M M Hawkins, C A Stiller, et al.
Journal of the National Cancer Institute|August 1, 1984
Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomasH Shimada, J Chatten, W A Newton, et al.
Medical and Pediatric Oncology|January 1, 1989
Histopathological classification of childhood rhabdomyosarcoma: a report from the International Society of Pediatric Oncology pathology panelJ M Caillaud, R Gérard-Marchant, H B Marsden, et al.
Journal of the National Cancer Institute|March 6, 1996
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancerM M Hawkins, L M Wilson, H S Burton, et al.
BMJ (Clinical Research Ed.)|April 11, 1992
Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancerM M Hawkins, L M Wilson, M A Stovall, et al.
Journal of Clinical Pathology|April 1, 1991
Congenital mesoblastic nephroma: possible prognostic and management value of assessing DNA contentJ C Barrantes, C Toyn, K R Muir, et al.
British Journal of Cancer|July 27, 2007
A study of soft tissue sarcomas after childhood cancer in BritainH C Jenkinson, D L Winter, H B Marsden, et al.
Pediatric Blood & Cancer|February 18, 2004
Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) studyR G Grundy, C Hutton, H Middleton, et al.
Pageof 8